Showing results (151-160 of 179) with videos related to

Sort By:
Pageof 18
Cancer Science|July 10, 2026
AI-Based Analysis of Tumor-Infiltrating Lymphocytes and Homologous Recombination in Ovarian Cancer: JGOG3025-A1 StudyKohei Hamada, Junzo Hamanishi, Noriomi Matsumura, et al.
JCI Insight|May 13, 2022
CXCL13-producing CD4+ T cells accumulate in the early phase of tertiary lymphoid structures in ovarian cancerMasayo Ukita, Junzo Hamanishi, Hiroyuki Yoshitomi, et al.
Cancer Immunology, Immunotherapy : CII|February 16, 2026
Title: AI-based quantification of tumor-infiltrating lymphocytes with integrative transcriptomics in ovarian clear cell carcinoma: JGOG3025-TR1/A1 studyKohei Hamada, Junzo Hamanishi, Akihiko Ueda, et al.
International Cancer Conference Journal|December 15, 2025
High-grade gliomas derived from an ovarian mature teratoma: clonal dynamics and genetic insightsKota Yamauchi, Junzo Hamanishi, Koichi Watanabe, et al.
Journal of Gynecologic Oncology|July 26, 2024
Niraparib in Japanese patients with platinum-sensitive recurrent ovarian cancer: final results of a multicenter phase 2 studyHiroaki Itamochi, Nobuhiro Takeshima, Junzo Hamanishi, et al.
Cancer Chemotherapy and Pharmacology|March 21, 2025
Population pharmacokinetic analysis of bevacizumab in Japanese cancer patients with proteinuria: a prospective cohort studyTakashi Masuda, Taro Funakoshi, Takahiro Horimatsu, et al.
Cancer Immunology, Immunotherapy : CII|February 1, 2025
Artificial intelligence-based spatial analysis of tertiary lymphoid structures and clinical significance for endometrial cancerHaruka Suzuki, Kohei Hamada, Junzo Hamanishi, et al.
The American Journal of Pathology|July 20, 2024
Artificial Intelligence-Based Histopathological Subtyping of High-Grade Serous Ovarian CancerAkihiko Ueda, Hidekatsu Nakai, Chiho Miyagawa, et al.
Scientific Reports|July 14, 2019
Analytical performance of a new automated chemiluminescent magnetic immunoassays for soluble PD-1, PD-L1, and CTLA-4 in human plasmaMegumi Goto, Kenji Chamoto, Keiko Higuchi, et al.
The American Journal of Pathology|March 20, 2016
Establishment of a Novel Histopathological Classification of High-Grade Serous Ovarian Carcinoma Correlated with Prognostically Distinct Gene Expression SubtypesRyusuke Murakami, Noriomi Matsumura, Masaki Mandai, et al.
Pageof 18